NasdaqCM - Nasdaq Real Time Price
USD
Aethlon Medical, Inc. (AEMD)
5.44
-0.08
(-1.45%)
At close: October 30 at 4:00:01 PM EDT
5.31
-0.13
(-2.39%)
After hours: October 30 at 4:38:37 PM EDT
Key Executives
Amounts are as of December 31, 2026 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. James B. Frakes M.B.A.
|
CEO, CFO, Chief Accounting Officer, Secretary & Director | 826.92k | -- | 1957 |
|
Dr. Steven P. LaRosa M.D.
|
Chief Medical Officer | 593.48k | -- | 1967 |
|
Ms. Michele Bombardiere
|
VP & Controller | -- | -- | -- |
Aethlon Medical, Inc.
11555 Sorrento Valley Road
Suite 203
San Diego, CA 92121
United States
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 9
Description
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
Corporate Governance
Aethlon Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 11, 2026 at 9:00 PM UTC
Aethlon Medical, Inc. Earnings Date
